Comparing the Inter-dental Brush to Dental Floss
Launched by UNIVERSITY OF BRITISH COLUMBIA · Aug 28, 2008
Trial Information
Current as of May 13, 2025
Completed
Keywords
ClinConnect Summary
Purpose:
To determine if the interdental brush is just as effective at removing plaque and reducing bleeding gums between the teeth as dental floss.
Rationale:
Many people find dental floss difficult to use and thus, do not floss daily to maintain oral health and prevent gum disease. These individuals may find the interdental brush easier to use and may be motivated to use it daily for optimal oral health.
Study design:
Study subjects will use the dental floss AND the interdental brush for 12 weeks. Plaque and bleeding scores will be measured before the study begins (week 0), mid-way (...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults
- • Minimum of 4 interproximal areas that can accommodate a minimum 0.6 mm interdental brush width
- • Minimum of 8 interproximal bleeding sites upon stimulation
- • Dexterity to use manual waxed dental floss
- • Able to attend all 4 study visits
- Exclusion Criteria:
- • Require premedication with antibiotics prior to dental therapy
- • Use chlorhexidine or over-the-counter mouthwash during the study
- • Smoke
- • Have orthodontia
About University Of British Columbia
The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vancouver, British Columbia, Canada
Patients applied
Trial Officials
Pauline Imai, MSc.
Principal Investigator
University of British Columbia
Penny Hatzimanolakis
Study Director
University of British Columbia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials